Inuvair inhalation solution

Inuvair is a prescription-only combination therapy used primarily for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). The brand belongs to Chiesi Farmaceutici, a major Italian pharmaceutical group known globally for its dedication to respiratory health.

Originally developed in Italy, the brand has grown into a staple for respiratory care across Europe and beyond. While manufacturing is heavily concentrated in Chiesi's advanced production facilities in Italy (specifically Parma), the brand's supply chain is international, reflecting its status as a global pharmaceutical product. Ownership remains under the Chiesi family through their private group, maintaining its roots in its founding city of Parma.